OncoCalendar

The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024. It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow […]

Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024. It is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss […]

The National Center for Complementary and Integrative Health (NCCIH) will celebrate its 25th anniversary by hosting a half-day symposium titled "Exploring the Impact of Whole Person Health" on Monday, December 2, 2024 at Bethesda, Maryland or Virtually. The event will feature the prestigious Stephen E. Straus Distinguished Lecture in the Science of Complementary Therapies, delivered […]

NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship will be held at October 24, 2025. The Asian Fund for Cancer Research, National Foundation for Cancer Research, and AIM-HI Accelerator Fund are co-hosting a dynamic event that will spotlight groundbreaking cancer research discoveries and the transformative impact of oncology innovation. This content-rich event will […]

The AORTIC PALOP VI Conference will be held from 5-7 December, 2024 at Luanda, Angola. The AORTIC PALOP VI Conference focuses on advancing cancer research and care in Portuguese-speaking African countries (PALOP). Organized by the African Organisation for Research and Training in Cancer (AORTIC), the event brings together healthcare professionals, researchers, and policymakers to discuss […]

Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily will be held from December 6-8, 2024. We are honored to invite you to the inaugural event of the Global Cancer Movement, an initiative by OncoDaily, aimed at advancing global collaboration in cancer research, treatment, and advocacy. This three-day virtual event will bring […]

The ESMO Asia Congress 2024 will be held at the Suntec Singapore Convention & Exhibition Centre, Singapore, on December 6-8. It is organized by the European Society for Medical Oncology. This key event brings together oncologists, researchers, and healthcare professionals from Asia and beyond to share the latest in cancer research, clinical trials, and treatment […]

The 66th ASH Annual Meeting and Exposition will take place from December 7-10, 2024, in San Diego, California, and online. The ASH annual meeting is the world's largest and most comprehensive hematology event of the year. With hundreds of sessions on the hottest trends in hematology, ASH offers multiple ways for attendees to find exactly […]

IOWG Grand Rounds - A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch will be held at December 8th, 2024. It is a Live Webinar will feature expert presentations from Dr. Ting Bao, Dr. Heather Greenlee, and Kathleen Sanders, who will provide valuable perspectives on integrating […]

NCI Cancer Integrative Medicine Grantee Virtual Conference will be held from December 10-11, 2024. This open-to-the-public event, with registration required, will focus on the integration of conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life. The conference aims to achieve two main objectives: Grantsmanship: It will provide valuable learning opportunities […]

3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 is a Virtual Event that will be held at December 11. 2024. The 3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 focuses on "Soft Tissue Sarcoma: Asian Challenge." This event aims to address the growing concern of soft tissue sarcomas (STS) […]